Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 118.44 -0.36 (-0.30%)
As of 04:13 AM Eastern

BBH vs. JMG, EDIN, FSV, TFG, IHP, HRI, GSS, BPCR, AGT, and BBGI

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include JPMorgan Emerging Markets (JMG), Edinburgh Investment (EDIN), Fidelity Investment Trust - Fidelity Special Values (FSV), Tetragon Financial (TFG), IntegraFin (IHP), Herald (HRI), Genesis Emerging Markets Fund (GSS), BioPharma Credit (BPCR), AVI Global Trust (AGT), and BBGI Global Infrastructure (BBGI). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Bellevue Healthcare (LON:BBH) and JPMorgan Emerging Markets (LON:JMG) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability.

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.1%. JPMorgan Emerging Markets pays an annual dividend of GBX 2 per share and has a dividend yield of 1.8%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. JPMorgan Emerging Markets pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bellevue Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

40.6% of Bellevue Healthcare shares are owned by institutional investors. Comparatively, 48.5% of JPMorgan Emerging Markets shares are owned by institutional investors. 0.1% of Bellevue Healthcare shares are owned by company insiders. Comparatively, 1.8% of JPMorgan Emerging Markets shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, JPMorgan Emerging Markets had 1 more articles in the media than Bellevue Healthcare. MarketBeat recorded 1 mentions for JPMorgan Emerging Markets and 0 mentions for Bellevue Healthcare. JPMorgan Emerging Markets' average media sentiment score of 1.05 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Emerging Markets is being referred to more favorably in the news media.

Company Overall Sentiment
Bellevue Healthcare Neutral
JPMorgan Emerging Markets Positive

Bellevue Healthcare has a net margin of 169.10% compared to JPMorgan Emerging Markets' net margin of 82.19%. JPMorgan Emerging Markets' return on equity of 6.30% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Bellevue Healthcare169.10% -4.48% N/A
JPMorgan Emerging Markets 82.19%6.30%1.55%

JPMorgan Emerging Markets has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Emerging Markets, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue Healthcare-£9.60M-30.42-£16.23M-£6.57-18.02
JPMorgan Emerging Markets£97.45M11.88£80.10M£7.5514.48

Bellevue Healthcare received 33 more outperform votes than JPMorgan Emerging Markets when rated by MarketBeat users. However, 75.73% of users gave JPMorgan Emerging Markets an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

CompanyUnderperformOutperform
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%
JPMorgan Emerging MarketsOutperform Votes
78
75.73%
Underperform Votes
25
24.27%

Summary

JPMorgan Emerging Markets beats Bellevue Healthcare on 12 of the 16 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£291.91M£1.20B£5.31B£2.64B
Dividend Yield3.82%4.41%4.18%5.05%
P/E Ratio-18.0221.9512.86134.69
Price / Sales-30.422,370.161,731.30224,245.30
Price / CashN/A60.4649.6228.03
Price / Book0.791.151.353.80
Net Income-£16.23M£263.32M£1.22B£5.88B
7 Day Performance-2.27%-0.10%0.05%0.43%
1 Month Performance-1.13%17.11%10.45%21.47%
1 Year Performance-16.12%2.57%13.64%129.56%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 118.44
-0.3%
N/A-16.8%£291.91M£-9,595,061.74-18.02N/A
JMG
JPMorgan Emerging Markets
N/AGBX 110.20
+0.5%
N/A+3.6%£1.17B£97.45M14.60N/A
EDIN
Edinburgh Investment
N/AGBX 781.71
+0.3%
N/A+9.0%£1.13B£189.32M6.25N/ATrending News
Earnings Report
FSV
Fidelity Investment Trust - Fidelity Special Values
N/AGBX 345.97
+0.3%
N/A+13.5%£1.12B£237.18M5.0325,000Positive News
TFG
Tetragon Financial
N/AGBX 13.72
-0.9%
N/AN/A£1.11B£22.12B8.80N/ANews Coverage
IHP
IntegraFin
3.3515 of 5 stars
GBX 328.50
+0.6%
GBX 406.67
+23.8%
-8.8%£1.09B£138.65M20.833,520News Coverage
Earnings Report
Dividend Increase
Analyst Forecast
Insider Trade
HRI
Herald
N/AGBX 2,158.33
+0.2%
N/A-2.5%£1.09B£162.63M6.236,600
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626Gap Down
BPCR
BioPharma Credit
N/AGBX 0.89
-0.2%
N/A+2.7%£1.05B£12.99B10.07N/A
AGT
AVI Global Trust
N/AGBX 234.96
-0.4%
N/A-3.7%£1.02B£219.59M4.72N/ANews Coverage
BBGI
BBGI Global Infrastructure
N/AGBX 142.20
flat
N/A+7.4%£1.01B£67.98M18.411,160

Related Companies and Tools


This page (LON:BBH) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners